Skip to content

Utah Medical Products UTMD Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
IAR
Integra LifeSciencesIART
PDE
Pro-Dex, Inc.PDEX
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
UFP Technologies logo
UFP TechnologiesUFPT

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's common stock, shares authorized (in shares)?
Utah Medical Products (UTMD) reported common stock, shares authorized (in shares) of $50M in Q1 2026.
How has Utah Medical Products's common stock, shares authorized (in shares) changed year-over-year?
Utah Medical Products's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $50M to $50M.
What is the long-term trend for Utah Medical Products's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Utah Medical Products's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $50M to $50M.